Literature DB >> 12874469

Early interstitial accumulation of collagen type I discriminates chronic rejection from chronic cyclosporine nephrotoxicity.

Rene C Bakker1, Klaas Koop, Yvo W Sijpkens, Michael Eikmans, Ingeborg M Bajema, Emile De Heer, Jan A Bruijn, Leendert C Paul.   

Abstract

Little is known regarding the composition of the interstitial extracellular matrix of kidney allografts with deteriorating function. Collagen I, III, and IV, the collagen IV alpha3 chain, and the laminin beta2 chain were investigated in biopsies of allografted kidneys with chronic cyclosporine A nephrotoxicity (CsAT) (n = 17), chronic rejection (CR) (n = 12), or chronic allograft nephropathy (CAN) (n = 19). alpha-Smooth muscle actin expression was also examined. Normal native kidneys were used as control samples (n = 11). Biopsy samples were studied with routine light microscopy and immunostaining. The mean interstitial fibrosis scores were significantly higher for the CR and CAN groups, compared with the chronic CsAT group. The cortical tubulointerstitial areas of the CR and CAN groups, but not the chronic CsAT group, contained more collagen I than did normal control samples. Differences were noted even in biopsies with mild fibrosis. Accumulation of collagen III, IV, and IV alpha3 was increased in all patient groups. Collagen III accumulation was greater in the CR and CAN groups than in the chronic CsAT group. Receiver-operating characteristic curve analysis demonstrated that collagen I staining had the best discriminatory value in differentiating CR from chronic CsAT, with a sensitivity of 63% and a specificity of 94% at a cutoff value of 19%. Laminin beta2 staining did not differentiate CR from CsAT. Increased alpha-smooth muscle actin staining did not differ among the three groups. It was concluded that, during chronic CsAT, collagen III and IV were preferentially accumulated in the tubulointerstitium. Early increases in the deposition of collagen I, with collagen III and IV, were more specific for CR. CR seems to elicit a more pronounced fibrotic response than does chronic CsAT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874469     DOI: 10.1097/01.asn.0000077345.81206.00

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  5 in total

1.  Chronic rejection of human face allografts.

Authors:  Nicco Krezdorn; Christine G Lian; Michael Wells; Luccie Wo; Sotirios Tasigiorgos; Shuyun Xu; Thiago J Borges; Rayven M Frierson; Ewelina Stanek; Leonardo V Riella; Bohdan Pomahac; George F Murphy
Journal:  Am J Transplant       Date:  2018-11-10       Impact factor: 8.086

2.  C4d staining in renal allograft biopsies with early acute rejection and subsequent clinical outcome.

Authors:  Johanna M Botermans; Hanneke de Kort; Michael Eikmans; Klaas Koop; Hans J Baelde; Marko J K Mallat; Kim Zuidwijk; Cees van Kooten; Emile de Heer; Natascha N T Goemaere; Frans H J Claas; Jan A Bruijn; Johan W de Fijter; Ingeborg M Bajema; Marian C van Groningen
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-28       Impact factor: 8.237

3.  Connective tissue growth factor gene expression and decline in renal function in lupus nephritis.

Authors:  Chiraporn Tachaudomdach; Surasak Kantachuvesiri; Siribha Changsirikulchai; Surangkana Wimolluck; Koset Pinpradap; Chagriya Kitiyakara
Journal:  Exp Ther Med       Date:  2012-02-03       Impact factor: 2.447

Review 4.  Composite tissue allotransplantation: opportunities and challenges.

Authors:  Jasper Iske; Yeqi Nian; Ryoichi Maenosono; Max Maurer; Igor M Sauer; Stefan G Tullius
Journal:  Cell Mol Immunol       Date:  2019-03-06       Impact factor: 11.530

Review 5.  Microvascular Inflammation of the Renal Allograft: A Reappraisal of the Underlying Mechanisms.

Authors:  Emilie Lebraud; Maëva Eloudzeri; Marion Rabant; Baptiste Lamarthée; Dany Anglicheau
Journal:  Front Immunol       Date:  2022-03-22       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.